A human 3D neuroinflammation model using BrainZell organoids with integrated bit.bio ioMicroglia
application note

A human 3D neuroinflammation model using BrainZell organoids with integrated bit.bio ioMicroglia

Developed and published by BrainZell, a CRO specialising in generating high-throughput brain organoids derived from human iPSCs.
Read application note
A human 3D neuroinflammation model using BrainZell organoids with integrated bit.bio ioMicroglia
Developed and published by BrainZell, a CRO specialising in generating high-throughput brain organoids derived from human iPSCs.

Human brain organoids often lack a functional immune component, limiting their ability to capture neuroimmune interactions. This application note demonstrates how integrating ioMicroglia enables a more physiologically relevant human 3D model with measurable inflammatory signalling, cytokine release, and pharmacological modulation.

The application note demonstrates:

  • Successful integration of ioMicroglia into BrainZell organoids, confirmed by IBA1 expression and microglia-like morphology
  • A robust inflammatory response following LPS stimulation, including increased TNF-α and IL-6 expression and secretion
  • Pharmacological modulation of inflammation using dexamethasone
  • Systems-level profiling of inflammatory pathway activation using Olink panels

Potential applications include:

  • Studying neuroinflammatory mechanisms in neurodegenerative and neuropsychiatric disease
  • Screening anti-inflammatory and immunomodulatory compounds
  • Assessing CNS inflammatory liabilities for advanced therapeutic modalities like gene therapies and biologics.
Read application note

Originally published by BrainZell.

Authors: Murgoci A.N., Pronk R.J., and Szeszula P.

Related pages

Products Learn about our range of human iPSC-derived cells for research and drug discovery
Our platform Discover the cell coding platform behind our cells
Contact us Talk to us to learn more about our team and products